469 related articles for article (PubMed ID: 30949502)
21. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
[TBL] [Abstract][Full Text] [Related]
22. lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.
Cui B; Li B; Liu Q; Cui Y
J Cell Biochem; 2017 Dec; 118(12):4548-4557. PubMed ID: 28475287
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
Wei N; Wei H; Zhang H
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
[TBL] [Abstract][Full Text] [Related]
25. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
[TBL] [Abstract][Full Text] [Related]
26. Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer.
Fang K; Caixia H; Xiufen Z; Zijian G; Li L
Biomed Res Int; 2020; 2020():9747826. PubMed ID: 32352014
[TBL] [Abstract][Full Text] [Related]
27. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489.
Xu D; Liu R; Meng L; Zhang Y; Lu G; Ma P
Biomed Pharmacother; 2018 Apr; 100():20-28. PubMed ID: 29421578
[TBL] [Abstract][Full Text] [Related]
29. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor.
Li H; Yan R; Chen W; Ding X; Liu J; Chen G; Zhao Q; Tang Y; Lv S; Liu S; Yu Y
FEBS J; 2021 Jan; 288(1):212-228. PubMed ID: 32255252
[TBL] [Abstract][Full Text] [Related]
30. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
[TBL] [Abstract][Full Text] [Related]
31. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Zhao X; Bai Z; Li C; Sheng C; Li H
Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
[TBL] [Abstract][Full Text] [Related]
33. [LncRNA ASB16-AS1 regulates the proliferation, migration and invasion of esophageal cancer cells by targeting miR-1258].
Jia Z; Wang PS; Yang Y; Zhu DY; Wang ZH; Wang W
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):762-768. PubMed ID: 34289570
[No Abstract] [Full Text] [Related]
34. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
35. Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
Chen X; Li D; Gao Y; Tang W; Iw L; Cao Y; Hao B
Cell Physiol Biochem; 2018; 46(3):1055-1064. PubMed ID: 29669323
[TBL] [Abstract][Full Text] [Related]
36. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.
Xiang Z; Lv Q; Chen X; Zhu X; Liu S; Li D; Peng X
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32735016
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
[TBL] [Abstract][Full Text] [Related]
38. TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.
Bao MH; Lv QL; Szeto V; Wong R; Zhu SZ; Zhang YY; Feng ZP; Sun HS
J Cell Physiol; 2020 May; 235(5):4594-4604. PubMed ID: 31637708
[TBL] [Abstract][Full Text] [Related]
39. MiR-15b/HOTAIR/p53 form a regulatory loop that affects the growth of glioma cells.
Sun G; Wang Y; Zhang J; Lin N; You Y
J Cell Biochem; 2018 Jun; 119(6):4540-4547. PubMed ID: 29323737
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]